Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

被引：14

作者：

Lukka, H. ^{[1
]}

Stephanie, P. ^{[2
]}

Bruner, D. ^{[3
]}

Bahary, J. P. ^{[4
]}

Lawton, C. A. F. ^{[5
]}

Efstathiou, J. A. ^{[6
]}

Kudchadker, R. ^{[7
]}

Ponsky, L. ^{[8
]}

Seaward, S. A. ^{[9
]}

Dayes, I. S. ^{[10
]}

Gopaul, D. D. ^{[11
]}

Michalski, J. M. ^{[12
]}

Delouya, G. ^{[13
]}

Kaplan, I. D. ^{[14
]}

Horwitz, E. M. ^{[15
]}

Roach, M., III ^{[16
]}

Pinover, W. H. ^{[17
]}

Beyer, D. C. ^{[18
]}

Sandler, H. M. ^{[19
]}

Kachnic, L. A. ^{[20
]}

机构：

[1] Juravinski Canc Ctr Hamilton Hlth Sci, Hamilton, ON, Canada

[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA

[3] Emory Univ, Atlanta, GA 30322 USA

[4] Hop Notre Dame CHUM, Montreal, PQ, Canada

[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[9] Kaiser Permanente No Calif, Santa Clara, CA USA

[10] McMaster Univ, Hamilton, ON, Canada

[11] Grand River Reg Canc Ctr, Kitchener, ON, Canada

[12] Washington Univ, Sch Med, St Louis, MO USA

[13] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[14] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[15] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[16] Univ Calif San Francisco, San Francisco, CA 94143 USA

[17] Abington Mem Hosp, Abington, PA 19001 USA

[18] Fdn Canc Res & Educ, Phoenix, AZ USA

[19] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[20] Boston Med Ctr, Boston, MA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2015.10.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA 3

引用

页码：2 / 2

页数：1

共 50 条

[31] NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results
Bruner, D. Watkins
Pugh, S. L.
Lee, W. R.
Dignam, J. J.
Low, D.
Swanson, G. P.
Shah, A. B.
D'Souza, D. P.
Michalski, J. M.
Dayes, I. S.
Seaward, S. A.
Nguyen, P. L.
Hall, W. A.
Pisansky, T. M.
Chen, Y.
Sandler, H. M.
Movsas, B.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S2 - S3
[32] Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study
Wenzel, Lari
Huang, Helen Q.
Cella, David
McKinney, Chelsea O.
Zevon, Michael A.
LaChance, Jason A.
Walker, Joan L.
Salani, Ritu
Modesitt, Susan C.
Morris, Robert T.
Bradley, William H.
Boente, Matthew P.
von Gruenigen, Vivian E.
GYNECOLOGIC ONCOLOGY, 2021, 163 (02) : 392 - 397
[33] Long Term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a Randomized Phase II Study of 2 SBRT Schedules for Lung Cancer
Videtic, G.
Paulus, R.
Singh, A.
Chang, J.
Parker, W.
Olivier, K.
Timmerman, R.
Komaki, R.
Urbanic, J.
Stephans, K.
Yom, S.
Robinson, C.
Belani, C.
Iyengar, P.
Ajlouni, M.
Gopaul, D.
Lele, S.
Mcgarry, R.
Choy, H.
Bradley, J.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1853 - S1854
[34] Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study (vol 30, pg 596, 2020)
Chase, D.
Huang, H. Q.
Monk, B. J.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (08) : 1267 - 1267
[35] Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+Breast Cancer With Brain Metastases: NRG Oncology - KROG/ RTOG 1119 Phase 2 Randomized Trial
Kim, In Ah
Winter, Kathryn A.
Sperduto, Paul W.
De Los Santos, Jennifer F.
Peereboom, David M.
Ogunleye, Tomi
Boulter, Daniel
Fritz, Joel M.
Cho, Kwan Ho
Shin, Kyung Hwan
Zoberi, Imran
Choi, Serah
Palmer, Joshua D.
Liem, Ben
Kim, Yong Bae
Anderson, Bethany M.
Thakrar, Anupama W.
Muanza, Thierry M.
Kim, Michelle M.
Choi, Doo Ho
Mehta, Minesh P.
White, Julia R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1391 - 1401
[36] IBRUTINIB FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): EVALUATING THE CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES AND DURABILITY OF RESPONSE IN A PHASE 2 STUDY
Rule, S.
Goy, A.
Martin, P.
Ramchandren, R.
Alexeeva, J.
Popat, R.
Avivi, I
Advani, R.
Le Gouill, S.
Horowitz, N.
Yuan, Z.
Kranenburg, B.
Zhuang, S. H.
Deraedt, W.
Rizo, A.
Wildgust, M.
Wang, M.
VALUE IN HEALTH, 2015, 18 (03) : A300 - A301
[37] Integrating weekly symptom monitoring for patients with prostate cancer in radiation oncology: A prospective cohort study using electronic patient-reported outcomes
Moller, P. K.
Pappot, H.
Schytte, T.
Bernchou, U.
Dieperink, K. B.
ANNALS OF ONCOLOGY, 2023, 34 : S1229 - S1229
[38] Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240) (vol 16, pg 301, 2015)
Penson, R. T.
Huang, H. Q.
Wenzel, L. B.
LANCET ONCOLOGY, 2016, 17 (01): : E6 - E6
[39] Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Rosenthal, Seth A.
Hu, Chen
Sartor, Oliver
Gomella, Leonard G.
Amin, Mahul B.
Purdy, James
Michalski, Jeff M.
Garzotto, Mark G.
Pervez, Nadeem
Balogh, Alexander G.
Rodrigues, George B.
Souhami, Luis
Reaume, M. Neil
Williams, Scott G.
Hannan, Raquibul
Horwitz, Eric M.
Raben, Adam
Peters, Christopher A.
Feng, Felix Y.
Shipley, William U.
Sandler, Howard M.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1159 - +
[40] Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial
Yang, Fan
Ghosh, Sunita
Yee, Don
Patel, Samir
Pervez, Nadeem
Parliament, Matthew
Usmani, Nawaid
Danielson, Brita
Amanie, John
Pearcey, Robert
Field, Colin
Fallone, Gino
Murtha, Albert
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (01): : 99 - 107

← 1 2 3 4 5 →